Scynexis stock price has resumed the downtrend following a restructuring of the GSK deal associated with considerable reduction of pending milestones.SCYX ended 2023 with $98M, but is still trading at...
Source LinkScynexis stock price has resumed the downtrend following a restructuring of the GSK deal associated with considerable reduction of pending milestones.SCYX ended 2023 with $98M, but is still trading at...
Source Link
Comments